Salta al contenuto
  • Italiano (it)Italiano
  • English (en)English
Dottor Alessandro Testori - Medico Chirurgo
|info@alessandrotestori.it
linkedinyoutubeEmail
Dr. Alessandro Testori Logo
  • Home
  • Melanoma e Tumori della Pelle
    • Immagini
  • Mappatura dei nei
  • Curriculum
    • Pubblicazioni
    • Congressi
  • Contatti
  • Visite
  • Consulti
Caricamento...
  • PUBBLICAZIONI

    Le Pubblicazioni Scientifiche di Alessandro Testori

TUTTE LE PUBBLICAZIONI SCIENTIFICHE DEL DOTTOR TESTORI

Pubblicazioniadmin2021-12-21T15:49:17+00:00
1.

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).

Saiag P, Gutzmer R, Ascierto PA, Maio M, Grob JJ, Murawa P, Dreno B, Ross M, Weber J, Hauschild A, Rutkowski P, Testori A, Levchenko E, Enk A, Misery L, Vanden Abeele C, Vojtek I, Peeters O, Brichard VG, Therasse P.

Ann Oncol. 2016 Aug 8. pii: mdw291. [Epub ahead of print]

PMID:
27502712

Similar articles

2.

Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors.

Campana LG, Testori A, Curatolo P, Quaglino P, Mocellin S, Framarini M, Borgognoni L, Ascierto PA, Mozzillo N, Guida M, Bucher S, Rotunno R, Marenco F, De Salvo GL, De Paoli A, Rossi CR, Bonadies A.

Eur J Surg Oncol. 2016 Jun 29. pii: S0748-7983(16)30606-0. doi: 10.1016/j.ejso.2016.06.399. [Epub ahead of print]

PMID:
27424789

Free Article

Similar articles

3.

The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients – An EORTC Melanoma Group study.

Oude Ophuis CM, Verhoef C, Rutkowski P, Powell BW, van der Hage JA, van Leeuwen PA, Voit CA, Testori A, Robert C, Hoekstra HJ, Grünhagen DJ, Eggermont AM, van Akkooi AC.

Eur J Surg Oncol. 2016 May 27. pii: S0748-7983(16)30163-9. doi: 10.1016/j.ejso.2016.05.012. [Epub ahead of print]

PMID:
27266406

Similar articles

4.

Pregnancy and melanoma: a European-wide survey to assess current management and a critical literature overview.

Ribero S, Longo C, Dika E, Fortes C, Pasquali S, Nagore E, Glass D, Robert C, Eggermont AM, Testori A, Quaglino P, Nathan P, Argenziano G, Puig S, Bataille V; Members of the Melanoma Group of the EORTC.

J Eur Acad Dermatol Venereol. 2016 May 27. doi: 10.1111/jdv.13722. [Epub ahead of print]

PMID:
27231086

Similar articles

5.

In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.

Bossi D, Cicalese A, Dellino GI, Luzi L, Riva L, D’Alesio C, Diaferia GR, Carugo A, Cavallaro E, Piccioni R, Barberis M, Mazzarol G, Testori A, Punzi S, Pallavicini I, Tosti G, Giacó L, Melloni G, Heffernan TP, Natoli G, Draetta GF, Minucci S, Pelicci P, Lanfrancone L.

Cancer Discov. 2016 Jun;6(6):650-63. doi: 10.1158/2159-8290.CD-15-1200. Epub 2016 May 13.

PMID:
27179036

Similar articles

6.

Sun exposure and melanoma prognostic factors.

Gandini S, Montella M, Ayala F, Benedetto L, Rossi CR, Vecchiato A, Corradin MT, DE Giorgi V, Queirolo P, Zannetti G, Giudice G, Borroni G, Forcignanò R, Peris K, Tosti G, Testori A, Trevisan G, Spagnolo F, Ascierto PA; CLINICAL NATIONAL MELANOMA REGISTRY GROUP.

Oncol Lett. 2016 Apr;11(4):2706-2714. Epub 2016 Mar 1.

PMID:
27073541

Free PMC Article

Similar articles

7.

Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.

Caini S, Radice D, Tosti G, Spadola G, Cocorocchio E, Ferrucci PF, Testori A, Pennacchioli E, Fargnoli MC, Palli D, Bazolli B, Botteri E, Gandini S.

J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1491-6. doi: 10.1111/jdv.13645. Epub 2016 Mar 18.

PMID:
26990937

Similar articles

8.

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity.

Eggermont AM, Suciu S, Rutkowski P, Kruit WH, Punt CJ, Dummer R, Salès F, Keilholz U, de Schaetzen G, Testori A; EORTC Melanoma Group.

Eur J Cancer. 2016 Mar;55:111-21. doi: 10.1016/j.ejca.2015.11.014. Epub 2016 Jan 17.

PMID:
26790144

Similar articles

9.

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

Bruno W, Pastorino L, Ghiorzo P, Andreotti V, Martinuzzi C, Menin C, Elefanti L, Stagni C, Vecchiato A, Rodolfo M, Maurichi A, Manoukian S, De Giorgi V, Savarese I, Gensini F, Borgognoni L, Testori A, Spadola G, Mandalà M, Imberti G, Savoia P, Astrua C, Ronco AM, Farnetti A, Tibiletti MG, Lombardo M, Palmieri G, Ayala F, Ascierto P, Ghigliotti G, Muggianu M, Spagnolo F, Picasso V, Tanda ET, Queirolo P, Bianchi-Scarrà G.

J Am Acad Dermatol. 2016 Feb;74(2):325-32. doi: 10.1016/j.jaad.2015.09.053.

PMID:
26775776

Similar articles

10.

Combined approach for the biomechanical characterization of skin lesions.

Franzetti G, Crippa F, Cutri E, Spatafora G, Montin E, Mainardi L, Spadola G, Testori A, Pennati G.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:913-6. doi: 10.1109/EMBC.2015.7318511.

PMID:
26736411

Similar articles

11.

Learning from mistakes: errors in approaches to melanoma and the urgent need for updated national guidelines.

Simionescu O, Blum A, Grigore M, Costache M, Avram A, Testori A.

Int J Dermatol. 2016 Sep;55(9):970-6. doi: 10.1111/ijd.13165. Epub 2015 Dec 29.

PMID:
26712381

Similar articles

12.

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd-6th 2014.

Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M, Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Arthur GM, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Typers, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2015 Nov 30;13:374. doi: 10.1186/s12967-015-0736-1.

PMID:
26619946

Free PMC Article

Similar articles

13.

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

Hersh EM, Del Vecchio M, Brown MP, Kefford R, Loquai C, Testori A, Bhatia S, Gutzmer R, Conry R, Haydon A, Robert C, Ernst S, Homsi J, Grob JJ, Kendra K, Agarwala SS, Li M, Clawson A, Brachmann C, Karnoub M, Elias I, Renschler MF, Hauschild A.

Ann Oncol. 2015 Nov;26(11):2267-74. doi: 10.1093/annonc/mdv324. Epub 2015 Sep 26.

PMID:
26410620

Similar articles

14.

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

Lebbe C, Becker JC, Grob JJ, Malvehy J, Del Marmol V, Pehamberger H, Peris K, Saiag P, Middleton MR, Bastholt L, Testori A, Stratigos A, Garbe C; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC).

Eur J Cancer. 2015 Nov;51(16):2396-403. doi: 10.1016/j.ejca.2015.06.131. Epub 2015 Aug 6. Review.

PMID:
26257075

Similar articles

15.

Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

Valpione S, Martinoli C, Fava P, Mocellin S, Campana LG, Quaglino P, Ferrucci PF, Pigozzo J, Astrua C, Testori A, Chiarion-Sileni V.

Eur J Cancer. 2015 Sep;51(14):2086-94. doi: 10.1016/j.ejca.2015.06.130. Epub 2015 Jul 27.

PMID:
26227432

Similar articles

16.

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.

Stratigos A, Garbe C, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag P, Middleton MR, Bastholt L, Testori A, Grob JJ; European Dermatology Forum (EDF); European Association of Dermato-Oncology (EADO); European Organization for Research and Treatment of Cancer (EORTC).

Eur J Cancer. 2015 Sep;51(14):1989-2007. doi: 10.1016/j.ejca.2015.06.110. Epub 2015 Jul 25. Review.

PMID:
26219687

Similar articles

17.

EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, Audisio RA, Zoras O, Lassmann M, Chakera AH, Uren R, Chondrogiannis S, Colletti PM, Rubello D.

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1750-66. doi: 10.1007/s00259-015-3135-1. Epub 2015 Jul 25.

PMID:
26205952

Similar articles

18.

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

Saiag P, Grob JJ, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Stratigos A, Middelton M, Basholt L, Testori A, Garbe C.

Eur J Cancer. 2015 Nov;51(17):2604-8. doi: 10.1016/j.ejca.2015.06.108. Epub 2015 Jul 16.

PMID:
26189684

Similar articles

22.

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.

Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbé C, Ferraresi V, Smylie M, Weber JS, Maio M, Konto C, Hoos A, de Pril V, Gurunath RK, de Schaetzen G, Suciu S, Testori A.

Lancet Oncol. 2015 May;16(5):522-30. doi: 10.1016/S1470-2045(15)70122-1. Epub 2015 Mar 31. Erratum in: Lancet Oncol. 2015 Jun;16(6):e262.

PMID:
25840693

Similar articles

23.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

Mozzillo N, Pasquali S, Santinami M, Testori A, Di Marzo M, Crispo A, Patuzzo R, Verrecchia F, Botti G, Montella M, Rossi CR, Caracò C.

Eur J Surg Oncol. 2015 Jul;41(7):823-9. doi: 10.1016/j.ejso.2015.02.005. Epub 2015 Mar 11.

PMID:
25800935

Similar articles

24.

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

Ferrucci PF, Minchella I, Mosconi M, Gandini S, Verrecchia F, Cocorocchio E, Passoni C, Pari C, Testori A, Coco P, Munzone E.

Melanoma Res. 2015 Jun;25(3):239-45. doi: 10.1097/CMR.0000000000000146.

PMID:
25746039

Similar articles

25.

Report from the second MIB (Melanoma Independent Board) Conference, 27-28 October 2014.

Testori A, Rossi CR, Ascierto P, de Lorenzo F, Mozzillo N.

Ecancermedicalscience. 2015 Feb 19;9:511. doi: 10.3332/ecancer.2015.511. eCollection 2015.

PMID:
25729424

Free PMC Article

Similar articles

26.

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial.

Maio M, Grob JJ, Aamdal S, Bondarenko I, Robert C, Thomas L, Garbe C, Chiarion-Sileni V, Testori A, Chen TT, Tschaika M, Wolchok JD.

J Clin Oncol. 2015 Apr 1;33(10):1191-6. doi: 10.1200/JCO.2014.56.6018. Epub 2015 Feb 23.

PMID:
25713437

Free Article

Similar articles

27.

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.

Di Giacomo AM, Ascierto PA, Queirolo P, Pilla L, Ridolfi R, Santinami M, Testori A, Simeone E, Guidoboni M, Maurichi A, Orgiano L, Spadola G, Del Vecchio M, Danielli R, Calabrò L, Annesi D, Giannarelli D, Maccalli C, Fonsatti E, Parmiani G, Maio M.

Ann Oncol. 2015 Apr;26(4):798-803. doi: 10.1093/annonc/mdu577. Epub 2014 Dec 23.

PMID:
25538176

Free Article

Similar articles

28.

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013.

Ascierto PA, Grimaldi AM, Anderson AC, Bifulco C, Cochran A, Garbe C, Eggermont AM, Faries M, Ferrone S, Gershenwald JE, Gajewski TF, Halaban R, Hodi FS, Kefford R, Kirkwood JM, Larkin J, Leachman S, Maio M, Marais R, Masucci G, Melero I, Palmieri G, Puzanov I, Ribas A, Saenger Y, Schilling B, Seliger B, Stroncek D, Sullivan R, Testori A, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2014 Oct 28;12:277. doi: 10.1186/s12967-014-0277-z.

PMID:
25348889

Free PMC Article

Similar articles

29.

Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013.

Testori A, Ascierto P, Chiarion Sileni V, De Lorenzo F, Pelicci P, Rossi C.

Ecancermedicalscience. 2014 Jun 30;8:440. doi: 10.3332/ecancer.2014.440. eCollection 2014.

PMID:
25075214

Free PMC Article

Similar articles

30.

Follow-up of cutaneous melanoma patients: a proposal for standardization.

Moscarella E, Ricci C, Borgognoni L, Bottoni U, Catricalà C, Dika E, Fanti PA, Landi C, Manganoni AM, Pellacani G, Peris K, Pimpinelli N, Quaglino P, Richetta A, Simonetti V, Stanganelli I, Testori A, Zalaudek I, Argenziano G.

G Ital Dermatol Venereol. 2014 Dec;149(6):633-8. Epub 2014 Jun 18. No abstract available.

PMID:
24938723

Similar articles

31.

Discrepant alterations in main candidate genes among multiple primary melanomas.

Colombino M, Sini M, Lissia A, De Giorgi V, Stanganelli I, Ayala F, Massi D, Rubino C, Manca A, Paliogiannis P, Rossari S, Magi S, Mazzoni L, Botti G, Capone M, Palla M, Ascierto PA, Cossu A, Palmieri G; Italian Melanoma Intergroup (IMI).

J Transl Med. 2014 May 8;12:117. doi: 10.1186/1479-5876-12-117.

PMID:
24885594

Free PMC Article

Similar articles

32.

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.

Ascierto PA, Simeone E, Sileni VC, Pigozzo J, Maio M, Altomonte M, Del Vecchio M, Di Guardo L, Marchetti P, Ridolfi R, Cognetti F, Testori A, Bernengo MG, Guida M, Marconcini R, Mandalà M, Cimminiello C, Rinaldi G, Aglietta M, Queirolo P.

J Transl Med. 2014 May 7;12:116. doi: 10.1186/1479-5876-12-116.

PMID:
24885479

Free PMC Article

Similar articles

33.

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme.

Chiarion Sileni V, Pigozzo J, Ascierto PA, Grimaldi AM, Maio M, Di Guardo L, Marchetti P, de Rosa F, Nuzzo C, Testori A, Cocorocchio E, Bernengo MG, Guida M, Marconcini R, Merelli B, Parmiani G, Rinaldi G, Aglietta M, Grosso M, Queirolo P.

J Exp Clin Cancer Res. 2014 Apr 4;33:30. doi: 10.1186/1756-9966-33-30.

PMID:
24708900

Free PMC Article

Similar articles

34.

The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis.

Caini S, Boniol M, Botteri E, Tosti G, Bazolli B, Russell-Edu W, Giusti F, Testori A, Gandini S.

J Dermatol Sci. 2014 Jul;75(1):3-9. doi: 10.1016/j.jdermsci.2014.02.007. Epub 2014 Mar 5. Review.

PMID:
24680127

Similar articles

35.

Treatment of metastatic melanoma with electrochemotherapy.

Campana LG, Testori A, Mozzillo N, Rossi CR.

J Surg Oncol. 2014 Mar;109(4):301-7. Review.

PMID:
24678530

Similar articles

36.

Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.

Tosti G, Cocorocchio E, Pennacchioli E, Ferrucci PF, Testori A, Martinoli C.

Expert Opin Biol Ther. 2014 Jul;14(7):955-67. doi: 10.1517/14712598.2014.902928. Epub 2014 Mar 26. Review.

PMID:
24670226

Similar articles

37.

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy.

Chiarion-Sileni V, Pigozzo J, Ascierto PA, Simeone E, Maio M, Calabrò L, Marchetti P, De Galitiis F, Testori A, Ferrucci PF, Queirolo P, Spagnolo F, Quaglino P, Carnevale Schianca F, Mandalà M, Di Guardo L, Del Vecchio M.

Br J Cancer. 2014 Apr 2;110(7):1721-6. doi: 10.1038/bjc.2014.126. Epub 2014 Mar 11.

PMID:
24619072

Free PMC Article

Similar articles

38.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.

Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U.

Ann Oncol. 2014 Mar;25(3):742-6. doi: 10.1093/annonc/mdt585. Epub 2014 Feb 7.

PMID:
24510314

Free PMC Article

Similar articles

39.

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.

McArthur GA, Chapman PB, Robert C, Larkin J, Haanen JB, Dummer R, Ribas A, Hogg D, Hamid O, Ascierto PA, Garbe C, Testori A, Maio M, Lorigan P, Lebbé C, Jouary T, Schadendorf D, O’Day SJ, Kirkwood JM, Eggermont AM, Dréno B, Sosman JA, Flaherty KT, Yin M, Caro I, Cheng S, Trunzer K, Hauschild A.

Lancet Oncol. 2014 Mar;15(3):323-32. doi: 10.1016/S1470-2045(14)70012-9. Epub 2014 Feb 7.

PMID:
24508103

Free PMC Article

Similar articles

40.

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program.

Ascierto PA, Simeone E, Sileni VC, Del Vecchio M, Marchetti P, Cappellini GC, Ridolfi R, de Rosa F, Cognetti F, Ferraresi V, Testori A, Queirolo P, Bernengo MG, Guida M, Galli L, Mandalà M, Cimminiello C, Rinaldi G, Carnevale-Schianca F, Maio M.

Cancer Invest. 2014 May;32(4):144-9. doi: 10.3109/07357907.2014.885984. Epub 2014 Jan 31.

PMID:
24484235

Similar articles

41.

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

Altomonte M, Di Giacomo A, Queirolo P, Ascierto P, Spagnolo F, Bajetta E, Calabrò L, Danielli R, de Rosa F, Maur M, Chiarion-Sileni V, Ferrucci P, Giannarelli D, Testori A, Ridolfi R, Maio M.

J Exp Clin Cancer Res. 2013 Oct 25;32:82. doi: 10.1186/1756-9966-32-82.

PMID:
24423086

Free PMC Article

Similar articles

42.

Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy.

Gandini S, De Vries E, Tosti G, Botteri E, Spadola G, Maisonneuve P, Martinoli C, Joosse A, Ferrucci PF, Baldini F, Cocorocchio E, Pennacchioli E, Cataldo F, Bazolli B, Clerici A, Barberis M, Bataille V, Testori A.

PLoS One. 2013 Nov 4;8(11):e78820. doi: 10.1371/journal.pone.0078820. eCollection 2013. Erratum in: PLoS One. 2014;9(7):e101732.

PMID:
24223851

Free PMC Article

Similar articles

43.

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma.

Del Vecchio M, Di Guardo L, Ascierto PA, Grimaldi AM, Sileni VC, Pigozzo J, Ferraresi V, Nuzzo C, Rinaldi G, Testori A, Ferrucci PF, Marchetti P, De Galitiis F, Queirolo P, Tornari E, Marconcini R, Calabrò L, Maio M.

Eur J Cancer. 2014 Jan;50(1):121-7. doi: 10.1016/j.ejca.2013.09.007. Epub 2013 Oct 4.

PMID:
24100024

Similar articles

44.

Lymphoscintigraphy in clinical routine practice: reproducibility and accuracy in melanoma patients with a long-term follow-up.

Vitali GC, Trifirò G, Zonta M, Pennacchioli E, Santoro L, Travaini LL, Barberis M, Testori A.

Eur J Surg Oncol. 2014 Jan;40(1):55-60. doi: 10.1016/j.ejso.2013.09.003. Epub 2013 Sep 12.

PMID:
24094681

Similar articles

45.

Maspin expression and melanoma progression: a matter of sub-cellular localization.

Martinoli C, Gandini S, Luise C, Mazzarol G, Confalonieri S, Giuseppe Pelicci P, Testori A, Ferrucci PF.

Mod Pathol. 2014 Mar;27(3):412-9. doi: 10.1038/modpathol.2013.157. Epub 2013 Sep 13.

PMID:
24030740

Free Article

Similar articles

46.

Pediatric melanoma: analysis of an international registry.

Averbook BJ, Lee SJ, Delman KA, Gow KW, Zager JS, Sondak VK, Messina JL, Sabel MS, Pittelkow MR, Ecker PM, Markovic SN, Swetter SM, Leachman SA, Testori A, Curiel-Lewandrowski C, Go RS, Jukic DM, Kirkwood JM.

Cancer. 2013 Nov 15;119(22):4012-9. doi: 10.1002/cncr.28289. Epub 2013 Sep 10.

PMID:
24022819

Free PMC Article

Similar articles

47.

Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?

Petralia G, Padhani A, Summers P, Alessi S, Raimondi S, Testori A, Bellomi M.

Eur Radiol. 2013 Dec;23(12):3466-76. doi: 10.1007/s00330-013-2968-x. Epub 2013 Jul 25.

PMID:
23884300

Similar articles

48.

Follow-up of melanoma: a survey of Italian hospitals.

Testori A, Chiarion-Sileni V, Stanganelli I, Rossi CR, Di Filippo F, Ridolfi R, Parmiani G, Gandini S, Soteldo J.

Dermatology. 2013;226 Suppl 1:32-8. doi: 10.1159/000348874. Epub 2013 May 29.

PMID:
23736269

Similar articles

50.

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

Chiarion-Sileni V, Guida M, Romanini A, Bernengo MG, Ascierto P, Queirolo P, Mandalà M, Maio M, Ferraresi V, Stanganelli I, Testori A, Ridolfi R.

Dermatology. 2013;226 Suppl 1:22-7. doi: 10.1159/000348870. Epub 2013 May 29.

PMID:
23736267

Similar articles

51.

Surgical management of suspicious melanocytic lesions in Italy.

De Giorgi V, Ascierto P, Bono R, Pimpinelli N, Chiarion-Sileni V, Palmieri G, Pizzichetta MA, Testori A, Stanganelli I.

Dermatology. 2013;226 Suppl 1:18-21. doi: 10.1159/000348864. Epub 2013 May 29.

PMID:
23736266

Similar articles

52.

Impact of mole mapping in the Italian health system.

Stanganelli I, Ascierto P, Bono R, De Giorgi V, Pimpinelli N, Chiarion-Sileni V, Palmieri G, Pizzichetta MA, Testori A.

Dermatology. 2013;226 Suppl 1:13-7. doi: 10.1159/000348863. Epub 2013 May 29.

PMID:
23736265

Similar articles

53.

Management of small and intermediate congenital nevi: a nationwide survey in Italy.

Stanganelli I, Ascierto P, Bono R, De Giorgi V, Pimpinelli N, Chiarion-Sileni V, Palmieri G, Pizzichetta MA, Testori A.

Dermatology. 2013;226 Suppl 1:7-12. doi: 10.1159/000348861. Epub 2013 May 29.

PMID:
23736264

Similar articles

54.

Diagnostic services for melanoma in Italy.

Stanganelli I, Ascierto P, Bono R, De Giorgi V, Pimpinelli N, Chiarion-Sileni V, Palmieri G, Pizzichetta MA, Testori A.

Dermatology. 2013;226 Suppl 1:3-6. doi: 10.1159/000348860. Epub 2013 May 29.

PMID:
23736263

Similar articles

55.

Melanoma Task Force (META) Project in Italy: methodology.

Mingozzi E, Fregosi S, Gandini S, Stanganelli I, Chiarion-Sileni V, Testori A.

Dermatology. 2013;226 Suppl 1:1-2. doi: 10.1159/000348858. Epub 2013 May 29.

PMID:
23736262

Similar articles

56.

Sentinel node biopsy in thin and thick melanoma.

Mozzillo N, Pennacchioli E, Gandini S, Caracò C, Crispo A, Botti G, Lastoria S, Barberis M, Verrecchia F, Testori A.

Ann Surg Oncol. 2013 Aug;20(8):2780-6. doi: 10.1245/s10434-012-2826-0. Epub 2013 May 30.

PMID:
23720068

Similar articles

57.

Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.

Kruit WH, Suciu S, Dreno B, Mortier L, Robert C, Chiarion-Sileni V, Maio M, Testori A, Dorval T, Grob JJ, Becker JC, Spatz A, Eggermont AM, Louahed J, Lehmann FF, Brichard VG, Keilholz U.

J Clin Oncol. 2013 Jul 1;31(19):2413-20. doi: 10.1200/JCO.2012.43.7111. Epub 2013 May 28.

PMID:
23715572

Free Article

Similar articles

58.

Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).

Busse A, Rapion J, Fusi A, Suciu S, Nonnenmacher A, Santinami M, Kruit WH, Testori A, Punt CJ, Dalgleish AG, Spatz A, Eggermont AM, Keilholz U.

Cancer Immunol Immunother. 2013 Jul;62(7):1223-33. doi: 10.1007/s00262-013-1428-4. Epub 2013 Apr 27.

PMID:
23624802

Similar articles

59.

Surgical management of melanoma: an EORTC Melanoma Group survey.

Testori A, Soteldo J, Powell B, Sales F, Borgognoni L, Rutkowski P, Lejeune F, van Leeuwen P, Eggermont A.

Ecancermedicalscience. 2013 Mar 28;7:294. doi: 10.3332/ecancer.2013.294. Print 2013.

PMID:
23589724

Free PMC Article

Similar articles

60.

Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma.

O’Day SJ, Eggermont AM, Chiarion-Sileni V, Kefford R, Grob JJ, Mortier L, Robert C, Schachter J, Testori A, Mackiewicz J, Friedlander P, Garbe C, Ugurel S, Collichio F, Guo W, Lufkin J, Bahcall S, Vukovic V, Hauschild A.

J Clin Oncol. 2013 Mar 20;31(9):1211-8. doi: 10.1200/JCO.2012.44.5585. Epub 2013 Feb 11.

PMID:
23401447

Free Article

Similar articles

61.

The cost of unresectable stage III or stage IV melanoma in Italy.

Maio M, Ascierto P, Testori A, Ridolfi R, Bajetta E, Queirolo P, Guida M, Romanini A, Chiarion-Sileni V, Pigozzo J, Di Giacomo AM, Calandriello M, Didoni G, van Baardewijk M, Konto C, Lucioni C.

J Exp Clin Cancer Res. 2012 Nov 1;31:91. doi: 10.1186/1756-9966-31-91.

PMID:
23116062

Free PMC Article

Similar articles

62.

Alternatives for the treatment of local advanced disease: electrochemotherapy, limb perfusion, limb infusion, intralesional IL2. What is the role?

Testori A, Intelisano A, Verrecchia F, Menicanti C, Tosti G, Grassi E, Pari C, Pennacchioli E.

Dermatol Ther. 2012 Sep-Oct;25(5):443-51. doi: 10.1111/j.1529-8019.2012.01486.x.

PMID:
23046023

Similar articles

63.

Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.

Eggermont AM, Suciu S, Testori A, Santinami M, Kruit WH, Marsden J, Punt CJ, Salès F, Dummer R, Robert C, Schadendorf D, Patel PM, de Schaetzen G, Spatz A, Keilholz U.

J Clin Oncol. 2012 Nov 1;30(31):3810-8. doi: 10.1200/JCO.2011.41.3799. Epub 2012 Sep 24.

PMID:
23008300

Free Article

Similar articles

64.

Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations.

Bertani E, Testori A, Chiappa A, Misitano P, Biffi R, Viale G, Mazzarol G, De Pas T, Botteri E, Contino G, Verrecchia F, Bazolli B, Andreoni B.

World J Surg Oncol. 2012 Sep 10;10:184.

PMID:
22963172

Free PMC Article

Similar articles

65.

Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.

van der Ploeg AP, van Akkooi AC, Rutkowski P, Cook M, Nieweg OE, Rossi CR, Testori A, Suciu S, Verhoef C, Eggermont AM; European Organization for Research and Treatment of Cancer Melanoma Group.

Br J Surg. 2012 Oct;99(10):1396-405. doi: 10.1002/bjs.8878.

PMID:
22961519

Similar articles

67.

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.

Di Giacomo AM, Ascierto PA, Pilla L, Santinami M, Ferrucci PF, Giannarelli D, Marasco A, Rivoltini L, Simeone E, Nicoletti SV, Fonsatti E, Annesi D, Queirolo P, Testori A, Ridolfi R, Parmiani G, Maio M.

Lancet Oncol. 2012 Sep;13(9):879-86. doi: 10.1016/S1470-2045(12)70324-8. Epub 2012 Aug 13.

PMID:
22894884

Similar articles

68.

Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).

Lebbe C, Lorigan P, Ascierto P, Testori A, Bédane C, Middleton M, van Baardewijk M, Konto C, Dueymes A, Maio M.

Eur J Cancer. 2012 Nov;48(17):3205-14. doi: 10.1016/j.ejca.2012.05.010. Epub 2012 Jun 27.

PMID:
22742880

Similar articles

69.

Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?

Pennacchioli E, Tosti G, Barberis M, De Pas TM, Verrecchia F, Menicanti C, Testori A, Mazzarol G.

Clin Exp Metastasis. 2012 Oct;29(7):757-73. doi: 10.1007/s10585-012-9502-4. Epub 2012 Jun 15.

PMID:
22699363

Similar articles

70.

Improved survival with MEK inhibition in BRAF-mutated melanoma.

Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D; METRIC Study Group.

N Engl J Med. 2012 Jul 12;367(2):107-14. doi: 10.1056/NEJMoa1203421. Epub 2012 Jun 4.

PMID:
22663011

Free Article

Similar articles

71.

The role of BRAF V600 mutation in melanoma.

Ascierto PA, Kirkwood JM, Grob JJ, Simeone E, Grimaldi AM, Maio M, Palmieri G, Testori A, Marincola FM, Mozzillo N.

J Transl Med. 2012 Jul 9;10:85. doi: 10.1186/1479-5876-10-85.

PMID:
22554099

Free PMC Article

Similar articles

72.

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).

Johnston K, Levy AR, Lorigan P, Maio M, Lebbe C, Middleton M, Testori A, Bédane C, Konto C, Dueymes A, Sbarigia U, van Baardewijk M.

Eur J Cancer. 2012 Sep;48(14):2175-82. doi: 10.1016/j.ejca.2012.03.003. Epub 2012 Apr 3.

PMID:
22480965

Similar articles

73.

Utility of electrochemotherapy in melanoma treatment.

Testori A, Rossi CR, Tosti G.

Curr Opin Oncol. 2012 Mar;24(2):155-61. doi: 10.1097/CCO.0b013e32834fcaa8. Review.

PMID:
22249204

Similar articles

74.

Ipilimumab targeting CD28-CTLA-4 axis: new hope in the treatment of melanoma.

Lens M, Testori A, Ferucci PF.

Curr Top Med Chem. 2012;12(1):61-6. Review.

PMID:
22196270

Similar articles

75.

Newly identified tumor antigens as promising cancer vaccine targets for malignant melanoma treatment.

Ferrucci PF, Tosti G, di Pietro A, Passoni C, Pari C, Tedeschi I, Cataldo F, Martinoli C, Testori A.

Curr Top Med Chem. 2012;12(1):11-31. Review.

PMID:
22196269

Similar articles

76.

Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.

Eggermont AM, Suciu S, Testori A, Kruit WH, Marsden J, Punt CJ, Santinami M, Salès F, Schadendorf D, Patel P, Dummer R, Robert C, Keilholz U, Yver A, Spatz A.

Eur J Cancer. 2012 Jan;48(2):218-25. doi: 10.1016/j.ejca.2011.09.028. Epub 2011 Nov 5.

PMID:
22056637

Similar articles

77.

Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.

Testori A, Verhoef C, Kroon HM, Pennacchioli E, Faries MB, Eggermont AM, Thompson JF.

J Surg Oncol. 2011 Sep;104(4):397-404. doi: 10.1002/jso.22028. Review.

PMID:
21858835

Similar articles

78.

Local and intralesional therapy of in-transit melanoma metastases.

Testori A, Faries MB, Thompson JF, Pennacchioli E, Deroose JP, van Geel AN, Verhoef C, Verrecchia F, Soteldo J.

J Surg Oncol. 2011 Sep;104(4):391-6. doi: 10.1002/jso.22029. Review.

PMID:
21858834

Similar articles

79.

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

Danielli R, Ridolfi R, Chiarion-Sileni V, Queirolo P, Testori A, Plummer R, Boitano M, Calabrò L, Rossi CD, Giacomo AM, Ferrucci PF, Ridolfi L, Altomonte M, Miracco C, Balestrazzi A, Maio M.

Cancer Immunol Immunother. 2012 Jan;61(1):41-8. doi: 10.1007/s00262-011-1089-0. Epub 2011 Aug 11.

PMID:
21833591

Similar articles

80.

The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.

di Pietro A, Tosti G, Ferrucci PF, Testori A.

Expert Opin Biol Ther. 2011 Oct;11(10):1395-407. doi: 10.1517/14712598.2011.605353. Epub 2011 Jul 30. Review.

PMID:
21801084

Similar articles

81.

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Robert C, Thomas L, Bondarenko I, O’Day S, Weber J, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller WH Jr, Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD.

N Engl J Med. 2011 Jun 30;364(26):2517-26. doi: 10.1056/NEJMoa1104621. Epub 2011 Jun 5.

PMID:
21639810

Free Article

Similar articles

82.

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O’Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA; BRIM-3 Study Group.

N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5.

PMID:
21639808

Free PMC Article

Similar articles

83.

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.

van der Ploeg AP, van Akkooi AC, Rutkowski P, Nowecki ZI, Michej W, Mitra A, Newton-Bishop JA, Cook M, van der Ploeg IM, Nieweg OE, van den Hout MF, van Leeuwen PA, Voit CA, Cataldo F, Testori A, Robert C, Hoekstra HJ, Verhoef C, Spatz A, Eggermont AM.

J Clin Oncol. 2011 Jun 1;29(16):2206-14. doi: 10.1200/JCO.2010.31.6760. Epub 2011 Apr 25.

PMID:
21519012

Free Article

Similar articles

84.

Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directions.

Roach M 3rd, Alberini JL, Pecking AP, Testori A, Verrecchia F, Soteldo J, Ganswindt U, Joyal JL, Babich JW, Witte RS, Unger E, Gottlieb R.

J Surg Oncol. 2011 May 1;103(6):587-601. doi: 10.1002/jso.21805. Review.

PMID:
21480253

Similar articles

85.

Aggressive digital papillary adenocarcinoma.

Rastrelli M, Soteldo J, Vitali GC, Mazzarol G, Trifiro G, Tosti G, Testori A.

Indian J Cancer. 2011 Jan-Mar;48(1):126-7. doi: 10.4103/0019-509X.76641. No abstract available.

PMID:
21330762

Free Article

Similar articles

86.

Anti-CTLA-4 antibody adjuvant therapy in melanoma.

Eggermont AM, Testori A, Maio M, Robert C.

Semin Oncol. 2010 Oct;37(5):455-9. doi: 10.1053/j.seminoncol.2010.09.009. Review.

PMID:
21074060

Similar articles

87.

Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach.

Testori A, Tosti G, Martinoli C, Spadola G, Cataldo F, Verrecchia F, Baldini F, Mosconi M, Soteldo J, Tedeschi I, Passoni C, Pari C, Di Pietro A, Ferrucci PF.

Dermatol Ther. 2010 Nov-Dec;23(6):651-61. doi: 10.1111/j.1529-8019.2010.01370.x. Review.

PMID:
21054709

Similar articles

88.

Sentinel node biopsy for high-risk cutaneous nonanogenital squamous cell carcinoma: a preliminary result.

Rastrelli M, Soteldo J, Zonta M, Trifirò G, Mazzarol G, Vitali GC, Mosconi M, Testori A.

Eur Surg Res. 2010;44(3-4):204-8. doi: 10.1159/000312649. Epub 2010 Jun 5.

PMID:
20523053

Similar articles

89.

Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies–EORTC 18991.

Bouwhuis MG, Suciu S, Testori A, Kruit WH, Salès F, Patel P, Punt CJ, Santinami M, Spatz A, Ten Hagen TL, Eggermont AM.

J Clin Oncol. 2010 May 10;28(14):2460-6. doi: 10.1200/JCO.2009.24.6264. Epub 2010 Apr 12.

PMID:
20385998

Free Article

Similar articles

90.

Radio-guided ultrasound lymph node localization: feasibility of a new technique for localizing and excising nonpalpable lymph nodes ultrasound suspicious for melanoma metastases.

Testori A, Rastrelli M, De Fiori E, Soteldo J, Della Vigna P, Trifirò G, Mazzarol G, Travaini LL, Verrecchia F, Ratto EL, Bellomi M.

Melanoma Res. 2010 Jun;20(3):197-202. doi: 10.1097/CMR.0b013e3283350527.

PMID:
20216241

Similar articles

91.

Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.

Maio M, Mackiewicz A, Testori A, Trefzer U, Ferraresi V, Jassem J, Garbe C, Lesimple T, Guillot B, Gascon P, Gilde K, Camerini R, Cognetti F; Thymosin Melanoma Investigation Group.

J Clin Oncol. 2010 Apr 1;28(10):1780-7. doi: 10.1200/JCO.2009.25.5208. Epub 2010 Mar 1.

PMID:
20194853

Free Article

Similar articles

92.

Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile?

Soteldo J, Ratto EL, Gandini S, Trifirò G, Mazzarol G, Tosti G, Rastrelli M, Verrecchia F, Baldini F, Testori A.

Melanoma Res. 2010 Apr;20(2):133-7. doi: 10.1097/CMR.0b013e3283324e40.

PMID:
20087232

Similar articles

93.

HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future.

Tosti G, di Pietro A, Ferrucci PF, Testori A.

Expert Rev Vaccines. 2009 Nov;8(11):1513-26. doi: 10.1586/erv.09.108. Review.

PMID:
19863242

Similar articles

94.

Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy.

Casula M, Muggiano A, Cossu A, Budroni M, Caracò C, Ascierto PA, Pagani E, Stanganelli I, Canzanella S, Sini M, Palomba G; Italian Melanoma Intergroup (IMI), Palmieri G.

BMC Cancer. 2009 Oct 3;9:352. doi: 10.1186/1471-2407-9-352.

PMID:
19799798

Free PMC Article

Similar articles

95.

Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).

Fusi A, Collette S, Busse A, Suciu S, Rietz A, Santinami M, Kruit WH, Testori A, Punt CJ, Dalgleish AG, Spatz A, Eggermont AM, Keilholz U.

Eur J Cancer. 2009 Dec;45(18):3189-97. doi: 10.1016/j.ejca.2009.09.004. Epub 2009 Sep 28.

PMID:
19793643

Similar articles

96.

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caracò C, Cochran AJ, Cook MG, Drzewiecki KT, Essner R, Even-Sapir E, Eggermont AM, Stopar TG, Ingvar C, Mihm MC Jr, McCarthy SW, Mozzillo N, Nieweg OE, Scolyer RA, Starz H, Thompson JF, Trifirò G, Viale G, Vidal-Sicart S, Uren R, Waddington W, Chiti A, Spatz A, Testori A; European Association of Nuclear Medicine-European Organisation for Research and.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1713-42. doi: 10.1007/s00259-009-1228-4.

PMID:
19714329

Similar articles

97.

Utility of adjuvant systemic therapy in melanoma.

Eggermont AM, Testori A, Marsden J, Hersey P, Quirt I, Petrella T, Gogas H, MacKie RM, Hauschild A.

Ann Oncol. 2009 Aug;20 Suppl 6:vi30-4. doi: 10.1093/annonc/mdp250. Review.

PMID:
19617295

Free PMC Article

Similar articles

98.

Surgery and radiotherapy in the treatment of cutaneous melanoma.

Testori A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A, Eggermont AM.

Ann Oncol. 2009 Aug;20 Suppl 6:vi22-9. doi: 10.1093/annonc/mdp257. Review.

PMID:
19617294

Free PMC Article

Similar articles

99.

Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.

Casula M, Alaibac M, Pizzichetta MA, Bono R, Ascierto PA, Stanganelli I, Canzanella S, Palomba G, Zattra E; Italian Melanoma Intergroup (IMI), Palmieri G.

BMC Dermatol. 2009 Jul 22;9:7. doi: 10.1186/1471-5945-9-7.

PMID:
19624835

Free PMC Article

Similar articles

100.

Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).

Eggermont AM, Bouwhuis MG, Kruit WH, Testori A, ten Hagen T, Yver A, Xu C.

Cancer Chemother Pharmacol. 2010 Mar;65(4):671-7. doi: 10.1007/s00280-009-1072-z. Epub 2009 Jul 21.

PMID:
19621225

Similar articles

101.

Clinical genetic testing for familial melanoma in Italy: a cooperative study.

Bruno W, Ghiorzo P, Battistuzzi L, Ascierto PA, Barile M, Gargiulo S, Gensini F, Gliori S, Guida M, Lombardo M, Manoukian S, Menin C, Nasti S, Origone P, Pasini B, Pastorino L, Peissel B, Pizzichetta MA, Queirolo P, Rodolfo M, Romanini A, Scaini MC, Testori A, Tibiletti MG, Turchetti D, Leachman SA, Bianchi Scarrà G; IMI, Italian Melanoma Intergroup.

J Am Acad Dermatol. 2009 Nov;61(5):775-82. doi: 10.1016/j.jaad.2009.03.039. Epub 2009 Jun 4.

PMID:
19500876

Similar articles

102.

Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group.

Bottomley A, Coens C, Suciu S, Santinami M, Kruit W, Testori A, Marsden J, Punt C, Salès F, Gore M, Mackie R, Kusic Z, Dummer R, Patel P, Schadendorf D, Spatz A, Keilholz U, Eggermont A.

J Clin Oncol. 2009 Jun 20;27(18):2916-23. doi: 10.1200/JCO.2008.20.2069. Epub 2009 May 11. Erratum in: J Clin Oncol. 2009 Sep 20;27(27):4630. Dosage error in published abstract; MEDLINEhttp://www.ncbi.nlm.nih.gov/pubmed abstract corrected.

PMID:
19433686

Free Article

Similar articles

103.

Cutaneous melanoma in the elderly.

Testori A, Soteldo J, Sances D, Mazzarol G, Trifirò G, Zonta M, Rastrelli M, Schenone F, Verrecchia F.

Melanoma Res. 2009 Jun;19(3):125-34. doi: 10.1097/CMR.0b013e328329fe95. Review.

PMID:
19381113

Similar articles

104.

Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literature.

Bertani E, Chiappa A, Testori A, Mazzarol G, Biffi R, Martella S, Pace U, Soteldo J, Vigna PD, Lembo R, Andreoni B.

Ann Surg Oncol. 2009 Jun;16(6):1642-9. doi: 10.1245/s10434-009-0439-z. Epub 2009 Mar 19.

PMID:
19296178

Similar articles

105.

Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).

Testori A, De Salvo GL, Montesco MC, Trifirò G, Mocellin S, Landi G, Macripò G, Carcoforo P, Ricotti G, Giudice G, Picciotto F, Donner D, Di Filippo F, Soteldo J, Casara D, Schiavon M, Vecchiato A, Pasquali S, Baldini F, Mazzarol G, Rossi CR; Italian Melanoma Intergroup.

Ann Surg Oncol. 2009 Jul;16(7):2018-27. doi: 10.1245/s10434-008-0273-8. Epub 2009 Jan 9.

PMID:
19132446

Similar articles

106.

A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.

Rocca A, Minucci S, Tosti G, Croci D, Contegno F, Ballarini M, Nolè F, Munzone E, Salmaggi A, Goldhirsch A, Pelicci PG, Testori A.

Br J Cancer. 2009 Jan 13;100(1):28-36. doi: 10.1038/sj.bjc.6604817.

PMID:
19127265

Free PMC Article

Similar articles

107.

Why vitamin D for cancer patients?

Gandini S, Francesco F, Johanson H, Bonanni B, Testori A.

Ecancermedicalscience. 2009;3:160. doi: 10.3332/ecancer.2009.160. Epub 2009 Sep 30.

PMID:
22276021

Free PMC Article

Similar articles

108.

Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations.

Vignoli M, Scaini MC, Ghiorzo P, Sestini R, Bruno W, Menin C, Gensini F, Piazzini M, Testori A, Manoukian S, Orlando C, D’Andrea E, Bianchi-Scarrà G, Genuardi M.

Melanoma Res. 2008 Dec;18(6):431-7. doi: 10.1097/CMR.0b013e328319412f.

PMID:
19011513

Similar articles

109.

Modification of lymphoscintigraphic sentinel node identification before and after excisional biopsy of primary cutaneous melanoma.

Trifirò G, Verrecchia F, Soteldo J, Zonta M, Pizzigoni S, Travaini LL, Baldini F, Tosti G, Mosconi M, Paganelli G, Mazzarol G, Testori A.

Melanoma Res. 2008 Dec;18(6):373-7. doi: 10.1097/CMR.0b013e328307c231.

PMID:
19011509

Similar articles

110.

Vitamin D and skin cancer: a meta-analysis.

Gandini S, Raimondi S, Gnagnarella P, Doré JF, Maisonneuve P, Testori A.

Eur J Cancer. 2009 Mar;45(4):634-41. doi: 10.1016/j.ejca.2008.10.003. Epub 2008 Nov 12. Review.

PMID:
19008093

Similar articles

111.

Oncophage: step to the future for vaccine therapy in melanoma.

di Pietro A, Tosti G, Ferrucci PF, Testori A.

Expert Opin Biol Ther. 2008 Dec;8(12):1973-84. doi: 10.1517/14712590802517970 . Review.

PMID:
18990084

Similar articles

112.

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

Eggermont AM, Suciu S, Santinami M, Testori A, Kruit WH, Marsden J, Punt CJ, Salès F, Gore M, Mackie R, Kusic Z, Dummer R, Hauschild A, Musat E, Spatz A, Keilholz U; EORTC Melanoma Group.

Lancet. 2008 Jul 12;372(9633):117-26. doi: 10.1016/S0140-6736(08)61033-8.

PMID:
18620949

Similar articles

113.

Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings.

Lens M, Ferrucci PF, Testori A.

Recent Pat Anticancer Drug Discov. 2008 Jun;3(2):105-13. Review.

PMID:
18537753

Similar articles

114.

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician’s choice of treatment for stage IV melanoma: the C-100-21 Study Group.

Testori A, Richards J, Whitman E, Mann GB, Lutzky J, Camacho L, Parmiani G, Tosti G, Kirkwood JM, Hoos A, Yuh L, Gupta R, Srivastava PK; C-100-21 Study Group.

J Clin Oncol. 2008 Feb 20;26(6):955-62. doi: 10.1200/JCO.2007.11.9941. Erratum in: J Clin Oncol. 2008 Aug 1;26(22): 3819.

PMID:
18281670

Free Article

Similar articles

115.

Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.

Hauschild A, Gogas H, Tarhini A, Middleton MR, Testori A, Dréno B, Kirkwood JM.

Cancer. 2008 Mar 1;112(5):982-94. doi: 10.1002/cncr.23251. Review.

PMID:
18236459

Free Article

Similar articles

116.

Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity.

Pagnanelli G, Bono R, Pizzichetta MA, Talamini R, Ascierto PA, Testori A, Stanganelli I; Italian Melanoma Intergroup (IMI).

Anticancer Res. 2007 Jul-Aug;27(4C):2939-44.

PMID:
17695474

Free Article

Similar articles

117.

Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases.

De Pas T, Spitaleri G, Pruneri G, Curigliano G, Noberasco C, Luini A, Andreoni B, Testori A, de Braud F.

Crit Rev Oncol Hematol. 2008 Jan;65(1):1-7. Epub 2007 Jul 19. Review.

PMID:
17658269

Similar articles

118.

Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma.

Elliott B, Scolyer RA, Suciu S, Lebecque S, Rimoldi D, Gugerli O, Musat E, Sharma RN, Lienard D, Keilholz U, Testori A, Eggermont A, MacKie R, Robert C, Cook M, Thompson JF, Angevin E, Spatz A; European Organization for Research and Treatment of Cancer Melanoma Group.

Clin Cancer Res. 2007 Jul 1;13(13):3825-30.

PMID:
17606713

Free Article

Similar articles

119.

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS, Testori A, Larue L, Goding CR.

Genes Dev. 2006 Dec 15;20(24):3426-39.

PMID:
17182868

Free PMC Article

Similar articles

120.

Cutaneous melanoma: digital dermoscopy-essential tool for positive diagnosis.

Simionescu O, Costache M, Testori A.

J Cell Mol Med. 2006 Oct-Dec;10(4):991-4.

PMID:
17125600

Free PMC Article

Similar articles

121.

Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survival.

Chiappa A, Zbar AP, Bertani E, Biffi R, Luca F, Crotti C, Testori A, Lazzaro G, De Pas T, Pace U, Andreoni B.

J Surg Oncol. 2006 May 1;93(6):456-63.

PMID:
16615149

Similar articles

122.

The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI).

Rossi CR, De Salvo GL, Trifirò G, Mocellin S, Landi G, Macripò G, Carcoforo P, Ricotti G, Giudice G, Picciotto F, Donner D, Di Filippo F, Montesco MC, Casara D, Schiavon M, Foletto M, Baldini F, Testori A.

J Nucl Med. 2006 Feb;47(2):234-41.

PMID:
16455628

Free Article

Similar articles

123.

Computer-aided diagnosis of melanocytic lesions.

Stanganelli I, Brucale A, Calori L, Gori R, Lovato A, Magi S, Kopf B, Bacchilega R, Rapisarda V, Testori A, Ascierto PA, Simeone E, Ferri M.

Anticancer Res. 2005 Nov-Dec;25(6C):4577-82.

PMID:
16334145

Free Article

Similar articles

124.

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.

Eggermont AM, Suciu S, MacKie R, Ruka W, Testori A, Kruit W, Punt CJ, Delauney M, Sales F, Groenewegen G, Ruiter DJ, Jagiello I, Stoitchkov K, Keilholz U, Lienard D; EORTC Melanoma Group.

Lancet. 2005 Oct 1;366(9492):1189-96.

PMID:
16198768

Similar articles

125.

Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk.

Lazzaro G, Lazzari R, Pelosi G, De Pas T, Mariani L, Mazzarol G, Sances D, Tosti G, Baldini F, Mosconi M, Tedeschi I, Viale G, Marsiglia H, Chiappa A, Vavassori A, Orecchia R, Testori A.

Ann Surg Oncol. 2005 Nov;12(11):935-42. Epub 2005 Oct 3.

PMID:
16195832

Similar articles

126.

Update: current management issues in malignant melanoma.

Queirolo P, Acquati M, Kirkwood JM, Eggermont AM, Rocca A, Testori A.

Melanoma Res. 2005 Oct;15(5):319-24. Review.

PMID:
16179860

Similar articles

127.

The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients.

Testori A, Lazzaro G, Baldini F, Tosti G, Mosconi M, Lovati E, Bossi C, Sanvito S, Stanganelli I, Mazzarol G, De Salvo GL, Trifirò G, Biffi R, Bellomi M.

Melanoma Res. 2005 Jun;15(3):191-8.

PMID:
15917701

Similar articles

128.

Heat shock proteins and their use as anticancer vaccines.

Parmiani G, Testori A, Maio M, Castelli C, Rivoltini L, Pilla L, Belli F, Mazzaferro V, Coppa J, Patuzzo R, Sertoli MR, Hoos A, Srivastava PK, Santinami M.

Clin Cancer Res. 2004 Dec 15;10(24):8142-6. Review. No abstract available.

PMID:
15623587

Free Article

Similar articles

129.

Diagnosis of melanoma in the elderly and surgical implications.

Testori A, Stanganelli I, Della Grazia L, Mahadavan L.

Surg Oncol. 2004 Dec;13(4):211-21. Review.

PMID:
15615659

Similar articles

130.

Melanoma – what is new in sentinel node biopsy and locoregional treatments in 2003? Report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003.

Rossi CR, Testori A, Mocellin S, Campana L, Lejeune F.

Melanoma Res. 2004 Oct;14(5):329-32.

PMID:
15457087

Similar articles

131.

What is new in melanoma research? Vaccines, Basic and Translational Research in 2003: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003.

Rescigno M, Testori A, Parmiani G.

Melanoma Res. 2004 Aug;14(4):241-3.

PMID:
15305152

Similar articles

132.

Dermatoscopic and histopathological diagnosis of primary and metastatic melanoma: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003.

Stanganelli I, Testori A, Pizzichetta MA, Cochran AJ.

Melanoma Res. 2004 Jun;14(3):231-5.

PMID:
15179194

Similar articles

133.

What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003.

Scarrà GB, Testori A, Mihm M.

Melanoma Res. 2004 Apr;14(2):77-84.

PMID:
15057035

Similar articles

134.

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.

Castelli C, Rivoltini L, Rini F, Belli F, Testori A, Maio M, Mazzaferro V, Coppa J, Srivastava PK, Parmiani G.

Cancer Immunol Immunother. 2004 Mar;53(3):227-33. Epub 2003 Dec 19. Review.

PMID:
14689240

Similar articles

135.

Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group.

Ascierto PA, Palmieri G, Botti G, Satriano RA, Stanganelli I, Bono R, Testori A, Bosco L, Daponte A, Caracò C, Chiofalo MG, Melucci MT, Calignano R, Tatangelo F, Cochran AJ, Castello G; Melanoma Cooperative Group.

Int J Oncol. 2003 Jun;22(6):1209-15.

PMID:
12738985

Similar articles

136.

[The method of the sentinel lymph node].

Testori A.

Chir Ital. 2002 Sep-Oct;54(5):759-60. Italian. No abstract available.

PMID:
12469474

Similar articles

137.

Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.

Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchianò A, Queirolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P, Parmiani G.

J Clin Oncol. 2002 Oct 15;20(20):4169-80. Erratum in: J Clin Oncol 2002 Dec 1;20(23):4610.

PMID:
12377960

Similar articles

138.

Surgical techniques of melanoma and sentinel node biopsy.

Testori A, Mozzillo N.

Semin Oncol. 2002 Aug;29(4):328-35. Review.

PMID:
12170435

Similar articles

139.

[Role of high resolution color-Doppler US of the sentinel node in patients with stage I melanoma].

Bossi MC, Sanvito S, Lovati E, De Fiori E, Testori A, Bellomi M.

Radiol Med. 2001 Nov-Dec;102(5-6):357-62. Italian.

PMID:
11779983

Similar articles

140.

The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer.

Eggermont AM, Keilholz U, Testori A, Cook M, Lienard D, Ruiter DJ.

Ann Surg Oncol. 2001 Oct;8(9 Suppl):38S-40S.

PMID:
11599896

Similar articles

141.

Epiluminescence microscopy features of melanoma in relation to tumor thickness. Current concepts and clinical examples.

Stanganelli I, Zago S, Testori A, Sforzini F, Zannetti G, Bucchi L.

Dermatol Clin. 2001 Apr;19(2):285-97. Review.

PMID:
11556237

Similar articles

142.

The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group.

Ruiter DJ, Testori A, Eggermont AM, Punt CJ.

Ann Oncol. 2001 Jan;12(1):9-11. No abstract available.

PMID:
11249056

Free Article

Similar articles

143.

Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience.

Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, Cavaliere R, Mozzillo N, Rossi CR, MacKie RM, Nieweg O, Pace M, Kirov K.

Ann Surg Oncol. 2000 Jul;7(6):469-74.

PMID:
10894144

Similar articles

144.

Sentinel node biopsy (SNB) was proposed to stage epidemoid cancer of the male genitals.

Testori A.

Melanoma Res. 1999 Dec;9(6):619-20. No abstract available.

PMID:
10661776

Similar articles

145.

Sentinel node localization in primary melanoma: learning curve and results.

Testori A, Bartolomei M, Grana C, Mezzetti M, Chinol M, Mazzarol G, Lazzari I, Paganelli G, Geraghty JG, Andreoni B, Veronesi U.

Melanoma Res. 1999 Dec;9(6):587-93.

PMID:
10661770

Similar articles

146.

Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance.

Gennari R, Bartolomei M, Testori A, Zurrida S, Stoldt HS, Audisio RA, Geraghty JG, Paganelli G, Veronesi U.

Surgery. 2000 Jan;127(1):19-25.

PMID:
10660754

Similar articles

147.

Rare presentation of small bowel leiomyosarcoma with liver metastases.

Testori A, Orsi F, Mazzarol G, Viale G, Marzona L, Andreoni B.

J Exp Clin Cancer Res. 1999 Sep;18(3):439-41.

PMID:
10606192

Similar articles

148.

An elderly patient with advanced locoregional melanoma.

Gennari R, Stoldt SH, Testori A, Geraghty JG.

Eur J Surg Oncol. 1999 Oct;25(5):550-1.

PMID:
10527609

Similar articles

149.

Medical decision making for melanoma of the glans penis.

Testori A, Mazzarol G, Viale G, De Cobelli O, Lotti M, Rocco F, Andreoni B.

J Exp Clin Cancer Res. 1999 Jun;18(2):219-21.

PMID:
10464710

Similar articles

150.

Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples.

Faraoni I, Graziani G, Turriziani M, Masci G, Mezzetti M, Testori A, Veronesi U, Bonmassar E.

Lab Invest. 1999 Aug;79(8):993-1005.

PMID:
10462037

Similar articles

151.

Sentinel node localisation: A new prospective in the treatment of nodal melanoma metastases.

Gennari R, Stoldt HS, Bartolomei M, Zurrida S, Testori A, Mazzarol G, Paganelli G, Veronesi U.

Int J Oncol. 1999 Jul;15(1):25-32. Review.

PMID:
10375590

Similar articles

152.

Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping.

Bartolomei M, Testori A, Chinol M, Gennari R, De Cicco C, Leonardi L, Zoboli S, Paganelli G.

Eur J Nucl Med. 1998 Nov;25(11):1489-94.

PMID:
9799344

Similar articles

153.

Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.

Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, Orsi F, Bellomi M, Mauri S, Aapro M, Andreoni B.

Eur J Cancer. 1997 Jul;33(8):1190-4.

PMID:
9301441

Similar articles

154.

Pretargeting strategies for radio-immunoguided tumour localisation and therapy.

Stoldt HS, Aftab F, Chinol M, Paganelli G, Luca F, Testori A, Geraghty JG.

Eur J Cancer. 1997 Feb;33(2):186-92. Review.

PMID:
9135486

Similar articles

155.

Radioimmunoguided surgery and colorectal cancer.

Aftab F, Stoldt HS, Testori A, Imperatori A, Chinol M, Paganelli G, Geraghty J.

Eur J Surg Oncol. 1996 Aug;22(4):381-8. Review.

PMID:
8783657

Similar articles

156.

Acral lentiginous melanoma. A histological type without prognostic significance.

Cascinelli N, Zurrida S, Galimberti V, Bartoli C, Bufalino R, Del Prato I, Mascheroni L, Testori A, Clemente C.

J Dermatol Surg Oncol. 1994 Dec;20(12):817-22.

PMID:
7798414

Similar articles

157.

Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation.

Scopsi L, Andreola S, Pilotti S, Bufalino R, Baldini MT, Testori A, Rilke F.

Am J Surg Pathol. 1994 Jul;18(7):702-11.

PMID:
8017565

Similar articles

158.

Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters.

Scopsi L, Andreola S, Pilotti S, Testori A, Baldini MT, Leoni F, Lombardi L, Hutton JC, Shimizu F, Rosa P, et al.

Am J Surg Pathol. 1992 Jun;16(6):561-76.

PMID:
1376022

Similar articles

159.

In vivo spectrophotometric evaluation of neoplastic and non-neoplastic skin pigmented lesions. II: Discriminant analysis between nevus and melanoma.

Marchesini R, Cascinelli N, Brambilla M, Clemente C, Mascheroni L, Pignoli E, Testori A, Venturoli DR.

Photochem Photobiol. 1992 Apr;55(4):515-22.

PMID:
1620728

Similar articles

160.

Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors.

Rilke F, Colnaghi MI, Cascinelli N, Andreola S, Baldini MT, Bufalino R, Della Porta G, Ménard S, Pierotti MA, Testori A.

Int J Cancer. 1991 Aug 19;49(1):44-9.

PMID:
1678734

Similar articles

161.

Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Cancer Institute of Milano, Italy (1971 to 1972 and 1977 to 1978).

Cascinelli N, Greco M, Morabito A, Bufalino R, Testori A, Baldini MT, Andreola S, Leo E, Galluzzo D, Rilke F.

Cancer. 1991 Jul 15;68(2):427-34.

PMID:
1649000

Free Article

Similar articles

162.

In vivo spectrophotometric evaluation of neoplastic and non-neoplastic skin pigmented lesions–I. Reflectance measurements.

Marchesini R, Brambilla M, Clemente C, Maniezzo M, Sichirollo AE, Testori A, Venturoli DR, Cascinelli N.

Photochem Photobiol. 1991 Jan;53(1):77-84.

PMID:
2027910

Similar articles

163.

Clinical status of diagnosis and therapy of malignant melanoma.

Belli F, Santinami M, Baldini MT, Testori A, Maio A, Cascinelli N.

Int J Rad Appl Instrum B. 1989;16(6):621-4. Review. No abstract available.

PMID:
2691455

Similar articles

164.

[Association of pseudohypoparathyroidism and skin melanoma: description of a case].

Baldini MT, Leo E, Belli F, Testori A, Bartoli C, Rovati M.

G Chir. 1988 Sep;9(9):591-3. Italian. No abstract available.

PMID:
3155225

Similar articles

165.

[Gastrointestinal metastasis of malignant melanoma].

Leo E, Belli F, Testori A, Baldini MT, Bartoli C, Rovati M.

G Chir. 1988 Jul-Aug;9(7-8):520-2. Italian. No abstract available.

PMID:
3155217

Similar articles

166.

Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skin.

Costa A, Silvestrini R, Grignolio E, Clemente C, Attili A, Testori A.

Cancer. 1987 Dec 1;60(11):2797-800.

PMID:
3677013

Free Article

Similar articles

Powered by Syrma srl Syrma-ai.it
Utilizziamo i cookie per essere sicuri che tu possa avere la migliore esperienza sul nostro sito. Se continui ad utilizzare questo sito noi assumiamo che tu ne sia felice.OkInformativa cookies